• Gamevice

  Participated · Series A · May 2017

  Gamevice develops an attachable gamepad controller that turns smartphones and tablets into hyper-advanced mobile gaming consoles. The company’s controllers are sold online and in approximately 490 Apple retail stores worldwide and support multiple iPhone and iPad models. Led by CEO Phillip Hyun, Gamevice offers products for iPhone 7/7 Plus, 6/6S/6 Plus/6S Plus, iPad Air, iPad Mini, and iPad Pro. The company is using new capital to launch additional products, increase production and global distribution, and expand its management team. David Jeon, formerly of Apple, Beats by Dre and Harman International, has joined as Head of Product Development. Kevin Chou, the former CEO of Kabam, has joined the company’s board.

• SnapMD

  Participated · Series A · Jan 2017

  SnapMD is a Los Angeles–based enterprise telehealth technology innovator offering a cloud-based Virtual Care Management (VCM) telehealth platform. Its white-label VCM software is HIPAA/HITECH/COPPA compliant and includes back-end systems to manage the digital health care continuum. The platform is configured to support multiple hospital and health system service lines with unique operational requirements and can be integrated with existing and future systems. The company intends to use the new funding to advance its telemedicine platform and accelerate sales and marketing efforts. SnapMD is led by president and CEO Dave Skibinski and has raised $16.3M in total capital to date. SnapMD offers a telemedicine platform designed to support standalone virtual clinics and a variety of provider workflows, and in 2016 documented more than 40 use cases for its product. The company aims to continue innovating its platform and deepen data and platform integrations. It has pursued channel partnerships to drive commercial adoption, notably with Konica Minolta and athenahealth’s More Disruption Please marketplace. SnapMD is also exploring integrations with services such as Iggby to enable physician-ordered lab studies during virtual visits. The CEO said this would be a tipping point year for telemedicine as health systems and outpatient care better define requirements and move to offer telemedicine themselves. The company has raised funding to support these priorities and expand sales through partners. SnapMD is a Los Angeles, CA-based healthcare IT company that provides a cloud-based, HIPAA-compliant private-label Virtual Care Management (VCM) telemedicine platform delivered via mobile phones, tablets and laptops. Led by CEO and co-founder Dave Skibinski and COO George Tierney, the company enables healthcare providers to engage their patients through its private-label solution. SnapMD completed the first closing of its Series A funding, raising $5.3M. The round was backed by Shea Ventures, TYLT Labs and Whittier Ventures. The company intends to use the funds to accelerate business development via direct sales and high-value channel partners and to enhance product development with core innovations to its VCM platform. SnapMD also plans to expand data integration capabilities and further scale its mobile app solutions. SnapMD provides a cloud-based telemedicine platform that enables one-on-one video, audio and text consultations between patients and their primary care and specialty care physicians. The platform supports scheduled consultations for patients undergoing active care as well as on-demand consultations to reduce avoidable emergency department visits. It can also be used for remote services such as in-school virtual clinics and to facilitate physician-to-physician communications. Led by CEO Dave Skibinski and COO George Tierney, the company intends to use the funds to expand sales, development and hiring efforts. SnapMD closed a $600K seed funding round to support those plans. The company is based in Los Angeles, CA.

• TodayTix

  Led · Series B · Feb 2016

  TodayTix is a mobile ticketing platform that helps users discover and buy tickets to theater and other live experiences. Founded in 2013, it began as a mobile equivalent of New York’s TKTS booths and has sold more than 4 million tickets. Those sales represent about 8% of annual Broadway ticket sales and 4% of London’s West End; the app currently offers tickets to 297 shows in New York and operates in 15 markets. The company plans to add more cities driven by partnerships and user demand and to expand offerings beyond traditional theater into comedy and experiential shows. TodayTix runs a TodayTix Presents program to produce shows at a smaller scale and is positioning itself as a media and discovery platform with curated content. Product investments include improved personalization, curation, and faster checkout flows (targeting purchases in 30 seconds or less). TodayTix is a mobile app that provides on-demand access to discounted and full-price last-minute theater tickets across key markets. Launched in December 2013 by Merritt Baer and Brian Fenty in New York City, the app operates in six markets including New York City, London, San Francisco Bay Area, Los Angeles, Washington DC and Chicago. The company has partnerships with more than 150 theater institutions globally and reports more than one million users. TodayTix says it now sells an average of two tickets per minute worldwide, quadrupled its sales and user base year-over-year, and accounts for four percent of all Broadway tickets; 54% of transactions are from repeat customers, 91% of users report seeing more shows due to the app, and over 45% see at least three additional shows per year. The Series B proceeds will be used to invest in product innovation, technology, geographic expansion and marketing to grow the user base and market reach. TodayTix offers a mobile-first ticketing app that lets users browse shows, pick showtimes and seats, pay on mobile, and optionally have tickets handed to them outside the theater. Launched by two Broadway producers (including Merritt Baer) and co-founder Brian Fenty, the app has gained rapid traction selling roughly 2–3% of tickets for most Broadway shows in New York City. In nine months since founding it hit a $20 million annual revenue run rate. The product is available on iOS, Android, and Amazon devices and targets a younger demographic (average customer age 32). The company plans to use funding to deepen its NYC presence, launch in London in Q1 2015, build a team of data scientists and technologists, and expand to other cities where touring theater is popular. TodayTix offers simple iOS and Android apps for buying last‑minute theater tickets up to a week in advance, with listings, seating charts and discounted and full‑price options. Six months after launch it had 120,000 users, 15 employees and was earning a 12% margin on purchases while sales were growing 40% per month. Forty percent of its users are active monthly, 40% of sales come from repeat customers, and roughly 50% of purchases in the app are for full‑price tickets. The app charges a flat $5 convenience fee per ticket, collects small commissions on box‑office pickups, and offers a $5 concierge pickup option. Currently only in New York City, TodayTix is preparing to launch in London’s West End this year and has expansion plans for Chicago, Las Vegas and beyond. To support growth it is working with mobile deep‑link retargeting systems like URX and has raised early capital to fund expansion.

• Pogoseat

  Participated · Seed · Jul 2014

  Pogoseat is a Los Angeles-based mobile app that lets fans instantly upgrade their seats or purchase in-game experiences at sporting events. Fans can buy upgrades the day of a game or during play through Pogoseat's app or partner apps to move closer to the field. The product enables franchises to capture incremental revenue from otherwise unsold or empty seats while driving loyalty among frequent attendees. Offerings extend beyond seat switches to booking mascot time, placing messages on the big screen, and other on-the-fly experiences. Pogoseat launched with the Golden State Warriors and counts clients including the Sacramento Kings, San Francisco Giants, Anaheim Ducks, Brooklyn Nets, and the Arena Football League. With $2.3M in seed funding, the company plans to expand its technology to more sports franchises and into concerts and other live events.

• PBC Tech

  Participated · Series A · Jun 2014

  Paper Battery Company has developed a proprietary, patented and scalable technology to produce ultra-thin, flexible ultracapacitors for devices such as smartphones, tablets, wearables, remote servers and Internet of Things products. Its first product line, PowerPatch, provides scalable voltage, energy and peak power in a single ultrathin package that can augment or work with lithium-ion batteries to improve battery life, thermal efficiency and signal effectiveness while reducing bill-of-materials cost. The company installed a new pilot production line, launched a commercial partnership with a battery pack manufacturer in Asia, and signed a test-and-evaluation contract with a potential large consumer-electronics customer. PowerPatch prototypes have been validated by customers, partners, and strategic investors, and the company has received recognition including a TIE50 2013 award and awards from the NY State Energy and Research Development Authority. The financing announced will be used to scale from the pilot line to commercial manufacturing and to achieve first sales revenues in 2015. The company is based in Troy, N.Y.

No current team members are available.